• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/39

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

39 Cards in this Set

  • Front
  • Back

Complications of untreated urinary tract obstruction

Infection (cystitis, pyelonephritis, abscess formation and sepsis)


Urinary extravasation


Fistula formation


Renal insufficiency or chronic kidney disease. Bladder dysfunction


Pain

investigations in primary care for male lower urinary tract symptoms

Urine dipstick +/- culture


Serum creatinine, eGFR, PSA


Frequency-Volume chart

investigations in secondary care for male lower urinary tract symptoms

Renal tract USS ± KUB x-ray


Urine flowmetry - for bladder outflow obstruction


Cystometry (urodynamics) - detrusor pressure


Flexible cystoscopy if urethral or bladder pathology is suspected

non-surgical management of BPH

Alter oral fluid intake, reduce caffeine intake


Stop anti-cholinergic, sympathomimetic and opioid drugs


α1-Adrenergic receptor blockers (e.g. tamsulosin)


5α-reductase inhibitors (e.g. finasteride)


anticholinergic if persistent symptoms of overactive bladder (OAB)


Catheterisation

complications of TURP / open prostatectomy

Postoperative haemorrhage and clot retention


UTI


TURP syndrome - hyponatraemia, hypotension and metabolic acidosis (2%)


Erectile dysfunction - retrograde ejaculation, impotence (5-35%)


Incontinence - 1%


Urethral stricture

presentation of renal cell carcinoma

haematuria


flank pain


abdominal mass


hypertension (↑renin)


polycythaemia (↑EPO)


ectopic hormone production: ACTH, ADH, PTHrp

renal cancer spread

Direct into renal vein and perirenal tissue


Lymphatic to periaortic and hilar nodes


Haematogenous to lung (large, ‘cannon-ball’ metastases), bones and contralateral kidney

bladder cancer spread

Direct into pelvic viscera (prostate, uterus, vagina, colon, rectum)


Lymphatic to periaortic nodes


Haematogenous to liver and lung

presentation of bladder cancer

Painless intermittent gross haematuria (95%)


Dysuria, urgency or frequency (10%)


In a smoker

treatment for bladder cancer

1. TURBT (resection of tumour)


2. Further management depends on type, stage, gradeand patient age

investigation for bladder cancer

flexible cystoscopy

prostate cancer spread

Direct into remainder of gland and seminal vesicles.


Lymphatic to iliac and periaortic nodes.


Haematogenous to bone (usually osteosclerotic lesions), liver, lung

PSA for prostate biopsy

PSA > 4 → prostatic biopsy

hormonal treatment used in management of advanced prostate cancer

1. anti-androgens


2. Androgen deprivation therapy (ADT) - LHRH agonists or bilateral orchidectomy


3. ADT + docetaxel chemotherapy (if metastatic)

2nd/3rd line Hormone therapy for those unfit for docetaxel

1. Combination LHRH agonist + anti-androgen


2. Steroids


3. Oestrogen


4. Bisphosphonates

types of testicular tumours

1. Germ cell tumours (95%) - seminoma, non-seminoma (embryonal, teratoma)


2. Non germ cell tumours (5%)


3. Metastatic tumours

testicular tumour markers

AFP, β-HCG and LDH

management of testicular cancer

Radicalorchidectomy (via groin incision)


+/- radiotherapy / chemotherapy

clinical presentation of renal tract stones

pain - can be in waves (colic), flank, lower abdomen, groin


haematuria


passing gravel


nauseaor vomiting


pain with urination


urgent need to urinate





types of renal tract stones

calcium oxalate (60%)


phosphate (30%) - struvite


uric acid (5%)


cystine (1%)

imaging for renal tract stones

spiral CT

initial management of renal tract stones

Pain relief


High fluid intake


Antiemetics

interventional procedures for renal tract stones

to drain urine: ureteric stent or percutaneous nephrostomy


to shrink stones: Extracorporeal shock wave lithotripsy (ESWL)


to remove stones: percutaneous nephrolithotomy or therapeutic ureteroscopy

differential diagnosis of scrotal mass

hernia, carcinoma, hydrocoele, epidydimal cyst, varicocoele, torsion, epididymoorchitis

indications for empirical antibiotic treatment for suspected UTI in non-pregnant women <65 years

severe or ≥ 3 symptoms of UTI without symptoms of pyelonephritis


treat with 3 days nitrofurantoin

indication for dipstick tests for suspected UTI in non-pregnant women <65 years

≤2 or mild symptoms of UTI


if dipstick positive treat with 3 days nitrofurantoin

indication for urine culture in non-pregnant women <65 years with UTI

urine culture if no response to trimethoprim or nitrofurantoin to guide change of antibiotic

indication for urine culture for men

symptoms of UTI

indication for urine dipstick test in older people

do not use dipsticks tests to diagnose UTIs in older people

treatment of UTI in men

nitrofurantoin PO for 7 days

treatment of UTI in patients with renal failure

avoid nitrofurantoin & tetracyclines


use trimethoprim or reduced dose amoxicillin

treatment of acute pyelonephritis

co-amoxiclav 1.2g TDS IV for 7 days


severe sepsis, add single dose gentamicin

treatment of acute prostatitis

co-amoxiclav 1.2g TDS IV for 28 days + gentamicin single dose

causes of haematuria

Upper tract causes: kidney stones, Renal cancer


Lower tract causes: inflammation or infection of the prostate or bladder, Stones, Bladder cancer, benign prostatic hyperplasia (BPH)




Top 3: ureteric stone, bladder carcinoma (TCC), BPH

investigations for non-visible haematuria

<40 years: USS & KUB x-ray


>40 years: CT-KUB

Investigations for visible haematuria

<40 years - CT KUB


>40 years - CT urogram

causes of retention of urine

bladder outflow obstruction, neurological, drugs, constipation

complications of bladder decompression via catheterisation

Haematuria


Transient hypotension


Post-obstructive diuresis

Indications for 2ww referral - NICE cancer referral guidelines (2015) for haematuria

1. Visible haematuria >45 years


2. Non-visible haematuria + raised WCC or dysuria,>60 years